MassBio®’s DEI Conference Brings Life Sciences Community Together to Advance Leadership in Inclusivity and Belonging

Jun 22, 2022

Fifth annual conference to spotlight best practices to address opportunities and challenges around diversity, equity, and inclusion

WHAT: MassBio’s 5th Annual Diversity, Equity and Inclusion (DEI) Conference will bring together life sciences leaders from across Massachusetts and beyond to learn, connect, and take action within their organizations, communities, and throughout the ecosystem at large. Through keynotes and panel discussions, experts will share their insights on the role of leaders in intentional conversations about inclusivity and belonging, current recruiting, retention, and development challenges, as well as non-traditional ways to build cultural intelligence and improve the employee experience, resulting in a highly productive workforce.

As a country, we learned from this global pandemic the value of science, crisis preparedness, what information to believe, and which leaders to follow. Throughout it all, industry collaboration was key to improvement. Diversity, equity, and inclusion resources, experiences, and perspectives were vital to our development of diagnostics, therapies, and vaccines. The life sciences industry demonstrated that diversity is fundamental to innovation and creativity, and in navigating this unprecedented crisis. 

WHEN: Thursday, July 21, 2022 | 1:00 PM – 4:45 PM (A networking reception will follow)

WHERE: MassBioHub, 700 Technology Square, 5th Floor, Cambridge, MA 02139 with a virtual option

WHO: The conference agenda features:

  • Keynote addresses from Nereyda García, Head, Ethics & Compliance, US Business Unit at Takeda on her personal experiences and some valuable principles of inclusive leadership put into practice at Takeda; and Patrice Matchaba, M.D., President, Novartis US Foundation, Novartis US Head for Corporate Responsibility highlighting the efforts of Novartis to ensure diversity and inclusion throughout the entire R&D Ecosystem in the US, not just in clinical trials, but also through the Beacon of Hope Program.
  • A panel discussion with Carolina Alarco, Co-Founder & Past-Chair, Latinos in Bio, Founder & Principal Bio Strategy Advisors; Ramsey Johnson, Founder, OUTBio and VP, Operations, Phoenix Tissue Repair; Don McAulay, Director of Diversity & Inclusion, Strategy & Operations, Thermo Fisher Scientific; and moderated by Wendy N. Richard, JD, MSSW, Director, Corporate Social Responsibility & Community Relations, US, Sanofi, on the role of intersectionality, or the ways in which multiple forms of discrimination intersect and reinforce each other, in recruitment and hiring, and how to better recognize and address unique forms of discrimination in the recruitment and selection processes.
  • Moderated by Marissa MacGauley, Head of GMP Recruitment, Bristol Myers Squibb, an expert panel will discuss how major shifts in the way people work in a post-COVID world present opportunities for meaningful change in corporate cultures as well as unintended consequences on established DEI initiatives. Panelists include Rodney Bolden, Vice President, Morgan Stanley at Work; Saraswathy Nochur, Chief DE&I Officer, Alnylam Pharmaceuticals; and Yuisa Pérez, Chief People Officer, Boston Museum of Science.
  • Remarks from MassBio leadership: CEO Joe Boncore, President & COO Kendalle Burlin O’Connell, Senior Director of DEI Advisory Ross Marshall, and Senior Director of DEI and Workforce Development Warner Santiago.

View the full agenda, here.

Interested media can register for free by contacting Ryan Boehm.

Sponsors of the event include Bristol Myers Squibb, Morgan Stanley, Novartis, Takeda, and ThermoFisher Scientific.

See all MassBio News